These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28348712)

  • 1. Azelnidipine, Not Amlodipine, Induces Secretion of Vascular Endothelial Growth Factor From Smooth Muscle Cells and Promotes Endothelial Tube Formation.
    Kawamura A; Miura SI; Matsuo Y; Tanigawa H; Saku K
    Cardiol Res; 2014 Oct; 5(5):145-150. PubMed ID: 28348712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway.
    Miura S; Fujino M; Matsuo Y; Tanigawa H; Saku K
    Hypertens Res; 2005 Feb; 28(2):147-53. PubMed ID: 16025742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species.
    Naito Y; Shimozawa M; Manabe H; Nakabe N; Katada K; Kokura S; Yoshida N; Ichikawa H; Kon T; Yoshikawa T
    Eur J Pharmacol; 2006 Sep; 546(1-3):11-8. PubMed ID: 16919261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
    Fujisawa M; Yorikane R; Chiba S; Koike H
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine increases nitric oxide synthesis in cytokine-stimulated cultured vascualar smooth muscle cells.
    Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Ikeda M; Minota S; Shimada K
    J Hypertens; 2000 Nov; 18(11):1597-604. PubMed ID: 11081772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of protein kinase C-nuclear factor-kappa B signal transduction pathway on proliferation and expression of vascular endothelial growth factor in human pulmonary artery smooth muscle cells].
    Zhang HP; Xu YJ; Zhang ZX; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):218-23. PubMed ID: 15144607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
    Ma J; Kishida S; Wang GQ; Meguro K; Imuta H; Oonuma H; Iida H; Jo T; Takano H; Morita T; Nagai R; Nakajima T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):314-21. PubMed ID: 16495772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
    Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
    J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
    Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
    Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice.
    Nakano K; Egashira K; Ohtani K; Gang Z; Iwata E; Miyagawa M; Sunagawa K
    Atherosclerosis; 2008 Jan; 196(1):172-179. PubMed ID: 17481639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells.
    Yao JS; Zhai W; Fan Y; Lawton MT; Barbaro NM; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):510-20. PubMed ID: 16820800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Fujisawa M; Yorikane R; Matsuoka Y; Koike H; Ueno K
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacological differences in anti-anginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Michio F; Ryosuke Y; Yuko M; Hiroyuki K; Koichi U
    J Cardiovasc Pharmacol; 2012 Oct; ():. PubMed ID: 23107869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actions of azelnidipine, a dihydropyridine-derivative Ca antagonist, on voltage-dependent Ba2+ currents in guinea-pig vascular smooth muscle.
    Zhu HL; Tomoda T; Aishima M; Ito Y; Teramoto N
    Br J Pharmacol; 2006 Nov; 149(6):786-96. PubMed ID: 17016499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan.
    Jinno T; Iwai M; Li Z; Li JM; Liu HW; Cui TX; Rakugi H; Ogihara T; Horiuchi M
    Hypertension; 2004 Feb; 43(2):263-9. PubMed ID: 14707152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells.
    Marumo T; Schini-Kerth VB; Busse R
    Diabetes; 1999 May; 48(5):1131-7. PubMed ID: 10331420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells.
    Marumo T; Schini-Kerth VB; Fisslthaler B; Busse R
    Circulation; 1997 Oct; 96(7):2361-7. PubMed ID: 9337212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
    Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
    Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.